Reliability and Validity of the Short-Form 12 Item Version 2 (SF− 12v2) Health-Related Quality of Life Survey and Disutilities Associated with Relevant Conditions in the US … CH Shah, JD Brown Journal of Clinical Medicine 9 (3), 661, 2020 | 47 | 2020 |
PSY10 THE ECONOMIC BURDEN OF SICKLE CELL DISEASE IN THE UNITED STATES J Huo, H Xiao, M Garg, C Shah, DJ Wilkie, A Mainous III Value in Health 21, S108, 2018 | 38 | 2018 |
Association between lung function and future risks of diabetes, asthma, myocardial infarction, hypertension and all-cause mortality CH Shah, RM Reed, Y Liang, Z Zafari ERJ open research 7 (3), 2021 | 13 | 2021 |
Economic burden of comorbidities among COPD patients hospitalized for acute exacerbations: An analysis of a commercially insured population CH Shah, E Onukwugha, Z Zafari, E Villalonga-Olives, J Park, JF Slejko Expert Review of Pharmacoeconomics & Outcomes Research 22 (4), 683-690, 2022 | 9 | 2022 |
Examining factors associated with adherence to hormonal therapy in breast cancer patients CH Shah, R Balkrishnan, V Diaby, H Xiao Research in Social and Administrative Pharmacy 16 (4), 574-582, 2020 | 6 | 2020 |
Quantifying heterogeneity of physical and mental health-related quality of life in chronic obstructive pulmonary disease patients in the United States CH Shah, RM Reed, E Villalonga-Olives, JF Slejko, MN Eakin, JY So, ... Expert review of respiratory medicine 14 (9), 937-947, 2020 | 5 | 2020 |
Disparities in prescription of opioids among prostate cancer patients of various racial groups CH Shah, H Xiao Pain management 9 (3), 273-281, 2019 | 3 | 2019 |
Trends in Medicaid spending on inhalers in the United States, 2012-2018 F Sistani, RM Reed, CH Shah, Z Zafari Journal of Managed Care & Specialty Pharmacy 27 (12), 1744-1749, 2021 | 2 | 2021 |
The state of use and utility of negative controls in pharmacoepidemiologic studies Z Zafari, J Park, CH Shah, S dosReis, EF Gorman, W Hua, Y Ma, F Tian American Journal of Epidemiology 193 (3), 426-453, 2024 | 1 | 2024 |
Direct Medical Costs of COPD in the USA: An Analysis of the Medical Expenditure Panel Survey 2017–2018 CH Shah, RM Reed, L Wastila, E Onukwugha, M Gopalakrishnan, Z Zafari Applied Health Economics and Health Policy 21 (6), 915-924, 2023 | 1 | 2023 |
Healthcare costs associated with comorbid cardiovascular and renal conditions among persons with diabetes, 2008–2019 CH Shah, CV Dave Diabetology & Metabolic Syndrome 14 (1), 179, 2022 | 1 | 2022 |
Direct medical and indirect absenteeism costs among working adult ADHD patients in the United States CH Shah, E Onukwugha Expert Review of Pharmacoeconomics & Outcomes Research 22 (6), 1013-1020, 2022 | 1 | 2022 |
PRS5 Direct Medical and Mortality Related Costs Among COPD Patients in the United States, 2017-2018 C Shah, Z Zafari Value in Health 24, S213, 2021 | 1 | 2021 |
Real-world changes in costs over time among patients in the United States with hereditary angioedema on long-term prophylaxis with lanadelumab CH Shah, N Princic, KA Evans, BG Schultz Journal of Medical Economics 26 (1), 871-877, 2023 | | 2023 |
Onychoscopy of nail lesions in dermatological disorders: A cross-sectional observational study A Sutaria, D Pol, K Dalave, MS Deora, YK Sharma, CH Shah Indian Journal of Dermatology 68 (1), 45-52, 2023 | | 2023 |
The Economic Burden of Chronic Obstructive Pulmonary Disease and Comparative Effectiveness of Maintenance Inhaler Medications in the United States C Shah | | 2023 |
HTA193 Criteria for Value Assessment of Medication Adherence-Enhancing Interventions: Preliminary Results of a Systematic Review T Agh, M Hiligsmann, I Jakab, C Beaudart, E Manias, B Borah, ... Value in Health 25 (12), S334, 2022 | | 2022 |
Trends in Medicaid spending on buprenorphine for treatment of opioid use disorder in Maryland, 2002-2020 CH Shah, D Qato, J Saini, Z Zafari APHA 2022 Annual Meeting and Expo, 2022 | | 2022 |
EE322 Direct Medical and Indirect Absenteeism Costs Among Working Adult ADHD Patients in the United States C Shah, E Onukwugha Value in Health 25 (7), S397, 2022 | | 2022 |
PRS8 Economic Burden of Comorbidities Among COPD Patients Experiencing Acute Exacerbations: an Analysis of a Commercially Insured Population C Shah, E Onukwugha, Z Zafari, EV Olives, JE Park, JF Slejko Value in Health 24, S214, 2021 | | 2021 |